Novavax, Inc.NVAXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank57
3Y CAGR-56.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-56.4%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$75.04M-63.0%
2024$202.74M-41.0%
2023$343.77M-61.9%
2022$902.64M-
2021$0.00-
2020$0.00-100.0%
2019$113.84M-
2018$0.00-
2017$0.00-100.0%
2016$237.94M-